Detection of C677T mutation in methylenetetrahydrofolate reductase gene by denaturing high performance liquid chromatography

Biomedical Chromatography

Volumn 18, Issue 9, 2004, Pages 625-629

  Fang, Nenghu ^a   Lin, Li ^a   Ren, Jicun ^a   Wu, Dan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Denaturing high performance liquid chromatography (DHPLC); Methylenetetrahydrofolate reductase (MTHFR); Mutation detection

Indexed keywords

BLOOD; DNA; ELECTROPHORESIS; GENES; POLYMERASE CHAIN REACTION; PURIFICATION;

CONDITION; DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; DNA FRAGMENT; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; METHYLENETETRAHYDROFOLATE REDUCTASE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; MUTATION DETECTION; PCR TECHNOLOGY; WHOLE BLOOD;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DNA FRAGMENT;

ANALYTICAL EQUIPMENT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA PURIFICATION; ELECTROPHORESIS; GENE AMPLIFICATION; GENE MUTATION; GENETIC VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 9944261903     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.364     Document Type: Article

References (26)

1. Andrea LA, Cunha M, Hirata H, Kim CA, Guerra-Shinohara EM, Nonoyama K and Hirata RDC. Metabolic effects of C677T and A1298C mutation at the MTHFR gene in Brazilian children with neural tube defects. Clinica Chimica Acta 2002; 18: 139.
2. Eng C, Brody C, Wagner TMU, Devilee P, Vijg J, Szabo C, Tavtigian SV, Nathanson KL, Ostrander E and Frank TS. Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. Journal of Medical Genetics 2001; 38: 824.
3. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP and Rozen R. Identification of a candidate genetic risk factor for vascular disease: a common mutation at the methylenetetrahydrofolate reductase locus. Nature and Genetics 1995; 10: 111.
4. Gallagher PM, Meleady R, Shields DC, Tan KS, McMaster D, Rozen R, Evans A, Graham IM and Whitehead AS. Homocysteine and risk of premature cornary heart disease: evidence for a common gene mutation. Circulation 1996; 94: 2154.
5. Hecker KH, Turpie B, Kuklin A. Optimization of cloning efficacy by pre-cloning DNA fragment analysis. BioTechniques 1999; 26: 216.
6. Hecker KH, Green SM and Kobayashi K. Analysis and purification of nucleic acids by ion-pair reversed-phase high-performance liquid chromatography. Biochemical and Biophysical Methods 2000; 46: 83.
7. Izumi M, Iwai N, Ohmichi N, Nakamura Y, Shimoike H and Kinoshita M. Molecular variant of 5,10-methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese population. Atherosclerosis 1996; 121: 293.
8. James GK, Jones MW and Pudek MR. Homocyst(e)ine levels in patients on phenytoin therapy. Clinical BioChemistry 1997; 30 647.
9. Kluijtmans LAJ, van den Heuvel PWJ, Boers GHJ, Frosst P, Stevens EMB, van Oost BA, den Heijer M, Trijbels FJ, Rozen R and Blom HJ. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. American Journal of Human Genetics 1996; 58: 35.
10. Kluijtmans LAJ, Kastelein JJP, Lindemans J, Boers GHJ, Heil SG, Bruschke AVG, Jukema JW, Van den Heuvel LPWJ, Trijbels FJM, Boerma GJM, Verheugt FWA, Willems F and Blom HJ. Thermolabile methylenetetrahydrofolate reducats in coronary artery disease. Circulation 1997; 96: 2573.
11. Kuklin A, Davis AP, Hecker KH, Gjerde DT and Taylor PD. A novel technique for rapid automated genotyping of DNA polymorphisms in the mouse. Molecular Cell Probes 1999; 13: 239.
12. Liu WO, Oefner PJ, Qian C, Odom RS and Francke U. Denaturing HPLC-identified novel FBN1 mutations, polymorphisms and sequence variants in Marfan syndrome and related connective tissue disorders. Genetic Testing 1997; 1: 237.
13. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, Maemura K, Minamino T, Ohno M, Yamaoki K, Ogasawara K, Aizawa T, Suzuki S and Yoshio, Genetic polymorphism of 5,10-methylenetetrahydrofolate reducatse (MTHFR) as a risk factor for coronary artery disease. Circulation 1997; 95: 2032.
14. Munson K, Haefele R, Kuklin A, Gjerde D and Taylor P. One application of the WAVE™ System is accurate and rapid sizing of DNA fragments. Application note no.107. Transgenomic: San Jose, CA, 1998. www.transgenomic.com/pdf/AN107.pdf
15. O'Donovan MC, Oefner PJ, Roberts S, Austin J, Guy C, Hoogendoorn B, Sommer S and McGuffin P. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics 1998; 52: 44.
16. Oefner PJ and Underhill PA. Current Protocols in Human Genetics, Dracopoli NC, Haines JL, Korf BR and Moir DT (eds). Wiley: New York, 1998; 7.10.1-7.10.12.
17. Ono H, Sakamoto A, Eguchi T, Fujita N, Nomura S, Ueda H, Sakura N and Ueda K. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants. Metabolism 1997; 46 959.
18. Ono H, Sakamoto A, Mizoguchi N and Sakura N. The C677T mutation iin the methylenetetrahydrofolate reducetase gene contributes to hyperhomocysteinemia in patients taking anticonvulsants. Brain and Development 2002; 24: 223.
19. Rozen P. Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid. Clinical Investigations in Medicine 1996: 19: 171.
20. Schwaninger M, Ringleb P, Winter R, Kohl B, Fiehn W and Rieser PA. Elevated homocysteine plasma concentrations during antiepileptic treatement. Epilepsia 1999, 40: 345.
21. Ulvik A, Ren J, Refsum H and Ueland PM. Simultaneous determination of methylenetetrahydrofolate reducatse C677T and factor V G1691A genotypes by mutagenically separated PCR and multiple-injection capillary electrophoresis. Clinical Chemistry 1998; 44: 264.
22. Underhill PA, Jin L, Lin AL, Mehdi, SQ, Jenkins T, Vollrath D, Davis R, Cavalli-Sforza LL and Oefner PJ. Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. Genome Research 1997; 7: 996.
23. Wagner TM, Moslinger RA, Muhr D, Langbauer G, Hirtenlehner K, Concin H, Doeller W, Haid A, Lang AH, Mayer P, Ropp E, Kubista E, Amirimani B, Helbich T, Becherer A, Scheiner O, Breiteneder H, Borg A, Devilee P and Oefner PJ. BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. International Journal of Cancer 1998; 77: 354.
24. Wagner T, Stoppa-Lyonnet D, Fleischmann E. Muhr D, Pagès S, Sandberg T, Caux V, Mölinger R, Langbauer G, Borg A and Oefner PJ. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics 1999a; 62: 369.
25. Wagner TM, Hirtenlehner K, Shen P, Moeslinger R, Muhr D, Fleishmann E, Concin H, Doeller W, Haid A, Lang AH, Mayer P, Petru E, opp E, Langbauer G, Kubista E, Scheiner O, Underhill P, Mountain J, Stierer M, Zielinski C and Oefner PJ. Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Human Molecular Genetics 1999b; 8: 413.
26. Xiao W and Oefner PJ. Denaturing high-performance liquid chromatography: a review. Human Mutation 2001; 17: 439.